Related Experiment Video
Updated: Apr 5, 2026

05:31
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
11.1K
Reducing Racial Disparities in Influenza Vaccination Among Children With Asthma
Summary
A new intervention significantly boosted influenza vaccination rates in children with asthma. This evidence-based approach also successfully reduced existing racial disparities in vaccination uptake.
Area of Science:
- Pediatric Primary Care
- Immunization Practices
- Public Health Interventions
Background:
- Asthma affects numerous children, increasing their risk for influenza complications.
- Low influenza vaccination rates remain a concern in pediatric populations, particularly among minority groups.
- Targeted interventions are needed to improve vaccine uptake in high-risk pediatric groups.
Purpose of the Study:
- To evaluate the impact of a multifaceted intervention on influenza vaccination rates in children with asthma.
- To assess whether the intervention reduced disparities in vaccination rates based on race.
Main Methods:
- A pre/post study design was employed across 18 primary care practices.
- The intervention involved the "4 Pillars Immunization Toolkit" and additional strategies.
- Influenza vaccination rates were compared before and after the intervention period (2 years), analyzing overall and race-specific data.
Main Results:
- Significant increases in influenza vaccination rates were observed in 13 out of 18 practices.
- Vaccination rates for non-White children rose from 46% to 61% (p < .01).
- Vaccination rates for White children increased from 58% to 65% (p < .001), and pre-intervention racial disparities were eliminated.
Conclusions:
- A comprehensive, evidence-based intervention effectively increased influenza vaccination uptake in children with asthma.
- The intervention successfully mitigated racial disparities in influenza vaccination rates.
- This strategy holds promise for improving immunization coverage in vulnerable pediatric populations.
Related Concept Videos
Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma: Pathogenesis and Management
1.7K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Asthma-IV: Nursing Management
4.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
4.1K
Asthma-I: Introduction
3.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Asthma-II: Pathophysiology and Classification
4.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.9K

